Epidemiology and management of group B streptococcal colonization during pregnancy in Africa

Area of Science:

• Maternal and child health
• Infectious disease epidemiology
• Neonatal intensive care

Background:

• Group B Streptococcus (GBS) is a major cause of neonatal morbidity and mortality globally.
• Maternal screening and intrapartum antimicrobial treatment effectively reduce GBS disease in Europe and North America.
• Limited data exists on GBS prevalence and neonatal disease incidence in low-income regions.

Purpose of the Study:

• To highlight the significance of GBS colonization and neonatal invasive disease in sub-Saharan Africa.
• To underscore the need for more epidemiological data on GBS in this region.
• To emphasize the necessity of assessing cost-effective prevention strategies for resource-poor settings.

Main Methods:

• Review of existing, albeit limited, data on GBS colonization prevalence in pregnant women in sub-Saharan Africa.
• Analysis of available reports on the incidence of neonatal invasive GBS disease in the region.
• Identification of knowledge gaps regarding GBS epidemiology in low-income settings.

Main Results:

• Emerging reports suggest GBS colonization rates in sub-Saharan Africa may be comparable to industrialized countries.
• Neonatal morbidity and mortality associated with GBS in this region are of significant concern.
• Substantial data gaps hinder the development of targeted prevention strategies.

Conclusions:

• GBS poses a significant threat to neonates in sub-Saharan Africa, necessitating urgent attention.
• Further research into GBS epidemiology in resource-poor settings is essential.
• Cost-effectiveness analyses of prevention strategies are crucial before implementation in low-income regions.